Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (531-540 of 706) with videos related to

Pageof 71
Sort By:
Clinical Cardiology|June 8, 2012
A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive CardiologyParag H Joshi, Sameer Chaudhari, Michael J Blaha, et al.
Journal of Thrombosis and Thrombolysis|September 9, 2004
Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarctionAjay J Kirtane, Anh Bui, Sabina A Murphy, et al.
Journal of Clinical Lipidology|November 12, 2019
Relationship between alirocumab, PCSK9, and LDL-C levels in four phase 3 ODYSSEY trials using 75 and 150 mg dosesJennifer G Robinson, Michel Farnier, John J P Kastelein, et al.
Cancer|December 22, 2006
Periosteal margin in soft-tissue sarcomaPatrick P Lin, Eduardo Diaz Pino, Anne N Normand, et al.
Clinical Cardiology|March 10, 2018
Sustained sex-based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease RegistryJacob A Udell, Gregg C Fonarow, Thomas M Maddox, et al.
Circulation. Cardiovascular Quality and Outcomes|September 20, 2012
Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trialSteen Husted, Stefan James, Richard C Becker, et al.
Drugs|June 21, 2020
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI TrialJosé C Nicolau, Deepak L Bhatt, Stefan H Hohnloser, et al.
American Heart Journal|September 5, 2021
Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed programJorge Plutzky, Mark D Benson, Kira Chaney, et al.
Clinical Cardiology|June 10, 2017
Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trialCharles V Pollack, Farideh Davoudi, Deborah B Diercks, et al.
JAMA Cardiology|March 5, 2020
Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
Pageof 71

Showing results (531-540 of 706) with videos related to

Sort By:
Pageof 71
Clinical Cardiology|June 8, 2012
A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive CardiologyParag H Joshi, Sameer Chaudhari, Michael J Blaha, et al.
Journal of Thrombosis and Thrombolysis|September 9, 2004
Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarctionAjay J Kirtane, Anh Bui, Sabina A Murphy, et al.
Journal of Clinical Lipidology|November 12, 2019
Relationship between alirocumab, PCSK9, and LDL-C levels in four phase 3 ODYSSEY trials using 75 and 150 mg dosesJennifer G Robinson, Michel Farnier, John J P Kastelein, et al.
Cancer|December 22, 2006
Periosteal margin in soft-tissue sarcomaPatrick P Lin, Eduardo Diaz Pino, Anne N Normand, et al.
Clinical Cardiology|March 10, 2018
Sustained sex-based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease RegistryJacob A Udell, Gregg C Fonarow, Thomas M Maddox, et al.
Circulation. Cardiovascular Quality and Outcomes|September 20, 2012
Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trialSteen Husted, Stefan James, Richard C Becker, et al.
Drugs|June 21, 2020
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI TrialJosé C Nicolau, Deepak L Bhatt, Stefan H Hohnloser, et al.
American Heart Journal|September 5, 2021
Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed programJorge Plutzky, Mark D Benson, Kira Chaney, et al.
Clinical Cardiology|June 10, 2017
Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trialCharles V Pollack, Farideh Davoudi, Deborah B Diercks, et al.
JAMA Cardiology|March 5, 2020
Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
Pageof 71